CD133 mAbs surface modified carbon nanotubes loaded with surviving siRNA & Paclitaxel for the treatment of non-small cell lung cancer | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

CD133 mAbs surface modified carbon nanotubes loaded with surviving siRNA & Paclitaxel for the treatment of non-small cell lung cancer

Implementing Organization

Principal Investigator

Dr. T.K. Praveen J.S.S. College of Pharmacy (Ooty) Tamil Nadu

Related Research

Funding Organization

Funding Organization

Department of Science and Technology (DST)

Quick Information

Area of Research

Medical Sciences

Focus Area

International Bilateral Cooperation (IBC)

Start Year

2020

End Year

2021

Duration

36

Sanction Amount

₹ 9.26 L

Status

Completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

00

No. of Patents

Filed : 00

Grant : 00

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Latest Updates

Loading…